Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: Involvement of cyclin-dependent kinase inhibitor p21 in polyploidization

Blood

Volumn 89, Issue 11, 1997, Pages 3980-3990

  Kikuchi, Jiro ^b   Furukawa, Yusuke ^a   Lwase, Satsuki ^b   Terui, Yasuhito ^b   Nakamura, Mitsuru ^b   Kitagawa, Seiichi ^b   Kitagawa, Masatoshi ^b   Komatsu, Norio ^b   Miura, Yasusada ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; BETA THROMBOGLOBULIN; CYCLIN DEPENDENT KINASE INHIBITOR; NOCODAZOLE; THROMBOCYTE FACTOR 4;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MEGAKARYOCYTE; NORTHERN BLOTTING; POLYPLOIDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030916345     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.3980     Document Type: Article

References (51)

1. Hoffman R: Regulation of megakaryocytopoiesis. Blood 74:1196, 1989
2. Avraham H: Regulation of megakaryocytopoiesis. Stem Cells 11:499, 1993
3. Odell TT, Jackson CW: Polyploidization and maturation of rat megakaryocytes. Blood 32:102, 1968
4. Brodsky WY, Uryvaeva IV: Cell polyploidy: Its relation to tissue growth and function. Int Rev Cytol 50:275, 1977
5. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato S, Wada H, Yawata Y, Suda T, Miura M: Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage coclony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51:341, 1991
6. Komatsu N, Fujita H: Induced megakaryocytic maturation of the human leukemia cell line UT-7 results in down-modulation of erythropoietin receptor gene expression. Cancer Res 53:1156, 1993
7. Ren H-Y, Komatsu N, Shimizu R, Okada K, Miura Y: Erythropoietin induces tyrosine phosphorylation and activation of phosholipase C-γ1 in a human erythropoietin-dependent cell line. J Biol Chem 269:19633, 1994
8. Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Miura Y: Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line UT-7/TPO. Blood 87:4552, 1996
9. Pines J: p21 inhibits cyclin shock. Nature 369:520, 1994
10. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
11. Steinman RA, Hoffmen B, Iro A, Guillouf C, Liebernmann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389, 1994
12. Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
13. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lasser AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018, 1995
14. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell cycle inhibitor Cip1/WAF1 and the E1 A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451, 1995
15. Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higash H, Saito S, Taya Y, Yasuda H, Ohba Y, Nishimura S, Tanaka N, Okuyama A: Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 8:2425, 1993
16. Kitagawa M, Higashi H, Suzuki-Takahashi I. Okabe T, Ogino H, Taya Y, Nishimura S, Okuyama A: A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 9:2549, 1994
17. Debili N, Issaad C, Massé J-M, Guichard J, Katz A, Breton-Gorius J, Vainchenker W: Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 80:3022, 1992
18. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402, 1995
19. Furukawa Y, DeCaprio JA, Freedman A, Kanakura Y, Nakamura M, Ernst TJ, Livingston DM, Griffin JD: Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci USA 87:2770, 1990
20. Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin JD, Saito M: Transforming growth factor-β inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem 267:17121, 1992
21. Terui Y, Furukawa Y, Kikuchi J, Saito M: Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J Cell Physiol 164:74, 1994
22. Lucibello FC, Sewing A, Brüsselbach S, Bürger C, Müller R: Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 105:123, 1993
23. Poncz M, Surrey S, LaRocco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E: Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219, 1987
24. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485, 1985
25. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
26. Terui Y, Furukawa Y, Sakoe K, Ohta M, Saito M: Expression of differentiation-related phenotypes and apoptosis are independently regulated during myeloid cell differentiation. J Biochem 117:77, 1995
27. Sakai T, Ohta M, Furukawa Y, Saga Y, Aizawa S, Kawakatsu H, Saito M: Tenascin-C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions. J Cell Physiol 165:18, 1995
28. Bartley TD, Bogenberger J, Hunt P, Li Y-S, Lu HS, Martin F, Chang M-S, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J,Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MC-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
29. Dunphy WG, Brizuela L, Beach D, Newport J: The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54:423, 1988
30. Chatelain C, De Bast M, Symann M: Enhancement of megakaryocyte polyploidization by actin inhibitor. Blood 80:497a, 1992 (abstr, suppl 1)
31. Mouthon M-A, Freund M, Titeux M, Katz A, Guichard J, Breton-Gorius J, Vainchenker W: Growth and differentiation of the human megakaryoblastic cell line (ELF-153): A model for early stages of megakaryocytopoiesis. Blood 84:1085, 1994
32. Hashimoto S, Toba K, Kishi K, Koike T, Shibata A: Growth and maturation effects of thrombopoietin on hematopoietic cell lines. Int J Hematol 63:230a, 1996
33. Hegyi E, Nakazawa M, Debili N, Navarro S, Katz A, Breton-Gorius J, Vainchenker W: Developmental changes in human megakaryocyte ploidy. Exp Hematol 19:87, 1991
34. Debili N, Hegyi E, Navarro S, Katz A, Mouthon M-A, Breton-Gorius J, Vainchenker W: In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood 77:2326, 1991
35. Shivdasani RA, Rosenblatt MF, Zurcker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH: Transcriptional factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995
36. Odell T, Jackson CM, Reiter RS: Generation cycle of rat megakaryocytes. Exp Cell Res 53:321, 1968
37. Graft G, Larkins BA: Endoreduplication in maize endosperm: Involvement of M phase-promoting factor inhibition and induction of S phase-related kinase. Science 269:1262, 1995
38. Lehner CF, O'Farrell PH: The roles of Drosophila cyclin A and cyclin B in mitotic control. Cell 61:535, 1990
39. Zhang Y, Wang Z, Ravid K: The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 271:4266, 1996
40. Usui T, Yoshida M, Abe K, Osada H, Isono K, Beppu T: Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J Cell Biol 115:1275, 1991
41. Xiong Y, Zhang H, Beach D: D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505, 1992
42. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
43. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90, 1994
44. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
45. Xiong Y, Zhang H, Beach D: Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572, 1993
46. Cip1 in muscle and other terminally differentiating cells. Science 267:1024, 1995
47. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267:1353, 1995
48. Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J, Bird CC: Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8:1397, 1993
49. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T: Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev 10:245, 1996
50. Sauer K, Knoblich JA, Richardson H, Lehner CF: Distinct modes of cyclin E/cdc2c kinase regulation and S-phase control in mitotic and endoreduplication cycles of Drosophila embryogenesis. Genes Dev 9:1327, 1995
51. Wilhide CC, Dang CV, Dipersio J, Kenedy AA, Bray PF: Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood 86:294, 1995